Singapoo - Kiingereza - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - posaconazole - suspension - 40mg/ml - posaconazole 40mg/ml

Malesia - Kiingereza - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - posaconazole -

Malesia - Kiingereza - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - posaconazole -

Israeli - Kiingereza - Ministry of Health

intervet ( israel) ltd - mometasone furoate (as monohydrate); orbifloxacin; posaconazole - ear drops suspension - orbifloxacin 8.5 mg/ml; mometasone furoate (as monohydrate) 0.9 mg/ml; posaconazole 0.9 mg/ml - dogs: treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular malassezia pachydermatis

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva b.v. - posaconazol 100 mg - gastro-resistant tablet - posaconazole

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva b.v. - posaconazol 100 mg - gastro-resistant tablet - posaconazole

Nyuzilandi - Kiingereza - Ministry for Primary Industries

schering-plough animal health limited - mometasone furoate monohydrate; posaconazole; orbifloxacin - mometasone furoate monohydrate 1 g/kg; posaconazole 1 g/kg; orbifloxacin 10 g/kg - antibiotic

Singapoo - Kiingereza - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - posaconazole - tablet, delayed release - posaconazole 100mg

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - posaconazole -

Singapoo - Kiingereza - HSA (Health Sciences Authority)

scientific resources pte ltd - general hospital - the chromsystems itraconazole, posaconazole, voriconazole in serum/plasma is an in vitro diagnostic device to be used in clinical laboratories for the quantitative detection of itraconazole, hydroxyitraconazole, posaconazole and voriconazole in human serum or plasma samples via high performance liquid chromatography (hplc). it is intended as a monitoring test for patients treated with one or more antimycotic drugs listed above as an aid to ensure drug levels are maintained within the therapeutic range.